Literature DB >> 9762601

Hunter disease in the Spanish population: molecular analysis in 31 families.

L Gort1, A Chabás, M J Coll.   

Abstract

Mucopolysaccharidosis type II (Hunter disease) is an X-linked disorder due to deficiency of the lysosomal enzyme iduronate 2-sulphatase. Here we report an update of molecular studies in 31 Spanish families with Hunter disease. We found a total of 22 novel small mutations (7 reported previously by our group), and 4 large deletions or rearrangements. Particularly relevant are two mutations, one showing an alternatively spliced product although the normal splice site is conserved; the other mutation results in an amino acid change that most likely modifies regulation of expression of the IDS gene. Except for large gene alterations and for the G374sp mutation already described, we could not establish a clear phenotype-genotype correlation. Mutation G374sp is the point mutation most frequent in our population (10%) and is always associated with mild phenotype. Our molecular analyses carried out in a relatively large series of patients with Hunter disease contribute to the identification of new mutations and reinforce the conclusions drawn in other populations about the genotype-phenotype correlation and the gene distribution of mutations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9762601     DOI: 10.1023/a:1005432600871

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  19 in total

1.  Mutation analysis in 20 patients with Hunter disease.

Authors:  S L Goldenfum; E Young; H Michelakakis; S Tsagarakis; B Winchester
Journal:  Hum Mutat       Date:  1996       Impact factor: 4.878

2.  Molecular analysis in 23 Hunter disease families.

Authors:  W Lissens; S Seneca; I Liebaers
Journal:  J Inherit Metab Dis       Date:  1997-07       Impact factor: 4.982

3.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

4.  Inversion of the IDS gene resulting from recombination with IDS-related sequences is a common cause of the Hunter syndrome.

Authors:  M L Bondeson; N Dahl; H Malmgren; W J Kleijer; T Tönnesen; B M Carlberg; U Pettersson
Journal:  Hum Mol Genet       Date:  1995-04       Impact factor: 6.150

5.  Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA.

Authors:  P J Wilson; C P Morris; D S Anson; T Occhiodoro; J Bielicki; P R Clements; J J Hopwood
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

6.  Iduronate-2-sulfatase gene mutations in 16 patients with mucopolysaccharidosis type II (Hunter syndrome).

Authors:  S Bunge; C Steglich; C Zuther; M Beck; C P Morris; E Schwinger; A Schinzel; J J Hopwood; A Gal
Journal:  Hum Mol Genet       Date:  1993-11       Impact factor: 6.150

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  Mucopolysaccharidosis type II (Hunter disease): 13 gene mutations in 52 Japanese patients and carrier detection in four families.

Authors:  Y Yamada; S Tomatsu; K Sukegawa; Y Suzuki; N Kondo; J J Hopwood; T Orii
Journal:  Hum Genet       Date:  1993-09       Impact factor: 4.132

9.  Mutations in the iduronate-2-sulfatase gene in five Norwegians with Hunter syndrome.

Authors:  T C Olsen; H G Eiken; P M Knappskog; B F Kase; J E Månsson; H Boman; J Apold
Journal:  Hum Genet       Date:  1996-02       Impact factor: 4.132

10.  Mutation analysis of Jewish Hunter patients in Israel.

Authors:  E Ben Simon-Schiff; G Bach; J J Hopwood; D Abeliovich
Journal:  Hum Mutat       Date:  1994       Impact factor: 4.878

View more
  9 in total

1.  A new polymorphism in the iduronate-2-sulphatase gene. Implications for the diagnosis of Hunter disease.

Authors:  L Gort; A Chabás; M J Coll
Journal:  J Inherit Metab Dis       Date:  1999-10       Impact factor: 4.982

2.  Clinical and Genetic Characteristics of Romanian Patients with Mucopolysaccharidosis Type II.

Authors:  Camelia Alkhzouz; Cecilia Lazea; Simona Bucerzan; Ioana Nascu; Eva Kiss; Carmencita Lucia Denes; Paula Grigorescu-Sido
Journal:  JIMD Rep       Date:  2016-06-29

3.  Mucopolysaccharidosis Type II and the G374sp Mutation.

Authors:  E Martínez-Quintana; F Rodríguez-González
Journal:  Mol Syndromol       Date:  2013-02-13

4.  Molecular characterization of Portuguese patients with mucopolysaccharidosis type II shows evidence that the IDS gene is prone to splicing mutations.

Authors:  S Alves; M Mangas; M J Prata; G Ribeiro; L Lopes; H Ribeiro; J Pinto-Basto; M Reis Lima; L Lacerda
Journal:  J Inherit Metab Dis       Date:  2006-10-25       Impact factor: 4.982

5.  Analysis of the IDS gene in 38 patients with Hunter syndrome: the c.879G>A (p.Gln293Gln) synonymous variation in a female create exonic splicing.

Authors:  Huiwen Zhang; Jing Li; Xinshun Zhang; Yu Wang; Wenjuan Qiu; Jun Ye; Lianshu Han; Xiaolan Gao; Xuefan Gu
Journal:  PLoS One       Date:  2011-08-04       Impact factor: 3.240

6.  Validation of the shortened Hunter Syndrome-Functional Outcomes for Clinical Understanding Scale (HS-FOCUS).

Authors:  Maria Mattera; Margaret K Vernon; Mireia Raluy-Callado; Jaromir Mikl
Journal:  Health Qual Life Outcomes       Date:  2018-11-08       Impact factor: 3.186

7.  Identification and Functional Characterization of IDS Gene Mutations Underlying Taiwanese Hunter Syndrome (Mucopolysaccharidosis Type II).

Authors:  Hsiang-Yu Lin; Ru-Yi Tu; Schu-Rern Chern; Yun-Ting Lo; Sisca Fran; Fang-Jie Wei; Sung-Fa Huang; Shin-Yu Tsai; Ya-Hui Chang; Chung-Lin Lee; Shuan-Pei Lin; Chih-Kuang Chuang
Journal:  Int J Mol Sci       Date:  2019-12-23       Impact factor: 5.923

Review 8.  Detection of Structural Variants by NGS: Revealing Missing Alleles in Lysosomal Storage Diseases.

Authors:  Valentina La Cognata; Sebastiano Cavallaro
Journal:  Biomedicines       Date:  2022-07-29

9.  Diverse clinical outcome of Hunter syndrome in patients with chromosomal aberration encompassing entire and partial IDS deletions: what is important for early diagnosis and counseling?

Authors:  Aleksandra Jezela-Stanek; Paulina Pokora; Marlena Młynek; Marta Smyk; Kamila Ziemkiewicz; Agnieszka Różdżyńska-Świątkowska; Anna Tylki-Szymańska
Journal:  Clin Dysmorphol       Date:  2021-04-01       Impact factor: 0.816

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.